Home Cart 0 Sign in  
X

[ CAS No. 6313-54-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 6313-54-8
Chemical Structure| 6313-54-8
Chemical Structure| 6313-54-8
Structure of 6313-54-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 6313-54-8 ]

Related Doc. of [ 6313-54-8 ]

Alternatived Products of [ 6313-54-8 ]

Product Details of [ 6313-54-8 ]

CAS No. :6313-54-8 MDL No. :MFCD00191402
Formula : C6H4ClNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :QXCOHSRHFCHCHN-UHFFFAOYSA-N
M.W : 157.55 Pubchem ID :236985
Synonyms :

Calculated chemistry of [ 6313-54-8 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 36.21
TPSA : 50.19 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.47 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.06
Log Po/w (XLOGP3) : 1.11
Log Po/w (WLOGP) : 1.43
Log Po/w (MLOGP) : -0.51
Log Po/w (SILICOS-IT) : 1.39
Consensus Log Po/w : 0.9

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.89
Solubility : 2.01 mg/ml ; 0.0128 mol/l
Class : Very soluble
Log S (Ali) : -1.76
Solubility : 2.76 mg/ml ; 0.0175 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.0
Solubility : 1.57 mg/ml ; 0.00998 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.39

Safety of [ 6313-54-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 6313-54-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 6313-54-8 ]
  • Downstream synthetic route of [ 6313-54-8 ]

[ 6313-54-8 ] Synthesis Path-Upstream   1~42

  • 1
  • [ 6313-54-8 ]
  • [ 13362-28-2 ]
Reference: [1] Helvetica Chimica Acta, 1951, vol. 34, p. 496,499
[2] Bioorganic and Medicinal Chemistry, 2005, vol. 13, # 12, p. 4022 - 4036
  • 2
  • [ 6313-54-8 ]
  • [ 22282-72-0 ]
Reference: [1] Journal of Organic Chemistry, 2006, vol. 71, # 25, p. 9420 - 9430
[2] Helvetica Chimica Acta, 1951, vol. 34, p. 496,499
  • 3
  • [ 33252-30-1 ]
  • [ 6313-54-8 ]
YieldReaction ConditionsOperation in experiment
92% at 60 - 65℃; for 2.4 h; Green chemistry General procedure: Aromatic or aliphatic nitriles (2 mmol) were dissolved in 5 ml of [bmim]HSO4 and the reaction mixture was heated at 60-65 °C for 1-3 h. The progress of reaction was monitored by TLC. After completion of reaction, as checked by TLC, the reaction mixture was poured into water containing crushed ice. The product was precipitated out, filtered and dried. The yield of the final product was high (>90percent) in all cases. All final products obtained were found sufficiently pure so it didn’t need further purification.The filtrate was concentrated under vacuum, washed with diethylether twice and concentrated under high vacuum. After proper drying under reduced pressure, approximately 95percent ionic liquid was recovered from the reaction and compared with the original ionic liquid to check its authenticity. The efficiency of recovered ionic liquid in conversion of nitriles to acids was found unchanged in comparison to the original one and we reused it up to 5-6 cycles without any significant loss of its activity.
Reference: [1] Tetrahedron Letters, 2014, vol. 55, # 28, p. 3802 - 3804
[2] Roczniki Chemii, 1955, vol. 29, p. 1019,1025[3] Chem.Abstr., 1956, p. 12045
  • 4
  • [ 58481-11-1 ]
  • [ 75-05-8 ]
  • [ 6313-54-8 ]
  • [ 1213232-78-0 ]
Reference: [1] Patent: US2007/219186, 2007, A1, . Location in patent: Page/Page column 38
  • 5
  • [ 13602-12-5 ]
  • [ 6313-54-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 6, p. 1667 - 1675
  • 6
  • [ 14906-37-7 ]
  • [ 6313-54-8 ]
Reference: [1] Cesko-Slovenska Farmacie, 1957, vol. 6, p. 369,370[2] Chem.Abstr., 1958, p. 10071
  • 7
  • [ 5398-44-7 ]
  • [ 6313-54-8 ]
Reference: [1] Helvetica Chimica Acta, 1947, vol. 30, p. 507,513
  • 8
  • [ 2402-95-1 ]
  • [ 6313-54-8 ]
Reference: [1] Roczniki Chemii, 1955, vol. 29, p. 1019,1025[2] Chem.Abstr., 1956, p. 12045
  • 9
  • [ 14432-12-3 ]
  • [ 6313-54-8 ]
Reference: [1] Roczniki Chemii, 1955, vol. 29, p. 1019,1025[2] Chem.Abstr., 1956, p. 12045
  • 10
  • [ 14432-16-7 ]
  • [ 6313-54-8 ]
Reference: [1] Roczniki Chemii, 1955, vol. 29, p. 1019,1025[2] Chem.Abstr., 1956, p. 12045
  • 11
  • [ 5398-44-7 ]
  • [ 7803-57-8 ]
  • [ 6313-54-8 ]
Reference: [1] Chemische Berichte, 1922, vol. 55, p. 2936
  • 12
  • [ 6313-54-8 ]
  • [ 18616-05-2 ]
Reference: [1] Journal of Organic Chemistry, 1958, vol. 23, p. 64
  • 13
  • [ 6313-54-8 ]
  • [ 100859-84-5 ]
Reference: [1] Patent: WO2006/35967, 2006, A1, . Location in patent: Page/Page column 90-91
  • 14
  • [ 6313-54-8 ]
  • [ 6937-03-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2005, vol. 13, # 12, p. 4022 - 4036
  • 15
  • [ 6313-54-8 ]
  • [ 74-88-4 ]
  • [ 58481-11-1 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 25℃; for 0.5 h; Inert atmosphere
Stage #2: at 50℃; for 2 h;
To a solution of 2-chloroisonicotinic acid (2.0 g, 0.0 12 mole) in DMF (5 mL)under N2 at 25 °C, was added sodium hydride (0.73 g, 0.0 15 mole) and stirred for 0.5hour. Methyl iodide (1.5 mL, 0.025 mole) was added at RT and the reaction mixturewas warmed to 50 °C for 2 hours. The reaction mixture was dissolved in ice water (50mL) and extracted with ethyl acetate (50 mL x 3). Organic layer was washed with brine solution (50 mL) and dried over Na2SO4. The organic phase was concentrated under vacuum to obtain methyl 2-chloroisonicotinate. Yield: 2.1 g (100 percent); Mass (mlz): 172.0 (M+H) , 174.0 (M+H) .
87% With sodium hydrogencarbonate In N,N-dimethyl-formamide at 20℃; for 20 h; Step 1: A mixture of 2-chloro-isonicotinic acid (4.0 g, 25.4 mmol), sodium bicarbonate (5.33 g, 63.48 mmol) and iodomethane (9.7 mL, 156.0 mmol) in N,N dimethyl formamide (60 mL) is stirred at room temperature for 20 hours. The mixture is poured into water and extracted with ether. The organic layer is washed with brine, dried over anhydrous sodium sulfate and filtered. Evaporation of the filtrate provides an oil which solidifies on standing to yield 3.8 g (87percent) of 2-chloro-isonicotinic acid methyl ester as a white solid. MS 172.0 [M+H].
Reference: [1] Patent: WO2017/42643, 2017, A1, . Location in patent: Page/Page column 24; 25
[2] Patent: WO2006/118256, 2006, A1, . Location in patent: Page/Page column 89
[3] Patent: US2007/219186, 2007, A1, . Location in patent: Page/Page column 38
  • 16
  • [ 67-56-1 ]
  • [ 6313-54-8 ]
  • [ 58481-11-1 ]
YieldReaction ConditionsOperation in experiment
91% at 70℃; for 5 h; 2-Chloro-isonicotinic acid (5.10 g, 32.38 mmol) was dissolved in methanol (150 mL). Thionyl chloride (12 mL) was added. This suspension was stirred 5 h at 70 0C and concentrated in vacuo. The residue was dissolved in dichloromethane (250 mL) washed with a solution of 10 percent aqueous K2CO3 (2 x 150 mL) dried with MgSO4, filtered and evaporated. Methyl 2-chloropyridine-4-carboxylate SLA 07150 was obtained as a yellow solid (5.06 g, 91 percent).SLA 07150 MW: 171.58; Yield: 91 percent; Yellow Solid; Mp (0C): 33.0. Rf\\ 0.80 (MeOH:CH2CI2 = 10:90).1H-NMR (CDCI3, δ): 3.98 (s, 3H, CH3), 7.78 (dd, 1 H, J = 5.1 Hz, J = 1.3 Hz, ArH), 7.89 (d, 1 H, J = 0.6 Hz ArH), 8.55 (dd, 1 H, J = 5.1 Hz, J = 0.6 Hz, ArH).
81% at 0 - 20℃; for 16 h; To a solution of 2-chloroisonicotinic acid 19-1 A (5 g, 31.8 mmol) in MeOH (50 mL) was added SOCl2 (2.7 mL, 38.2 mmol) portion-wise at 0 °C, and the mixture was stirred at RT for 16 hr. Solvent was evaporated under reduced pressure. The reaction was quenched with saturated sodium carbonate and diluted with EtOAc (50 mL) washed with water (50 mL), brine (20 mL) and dried over Na2S04, and the organic phase was concentrated under reduced pressure. Obtained crude compound was purified using silica gel chromatography (15percent EtOAc in hexanes) to afford 19- 2A (4.4 g, 25.7 mmol, 81percent yield) as an off-white solid. MS (ESI): m/z 172.1 (M+l)+.
75% for 3 h; Heating / reflux Preparation 1; SYNTHESIS OF 2-[4-(5-FLUORO-2-TRIFLUOROMETHYLBENZOYL)PIPERAZIN-1-YL]ISONICOTINIC ACID METHYL ESTER; A. A mixture of 2-chloroisonicotinic acid (1.000 g, 6.340 mmol) and 5 drops of concentrated sulfuric acid in anhydrous methanol (50 mL) was refluxed for 3 hours. The reaction mixture was concentrated in vacuo, diluted with 20 mL of water and extracted with ethyl acetate. The organic phase was washed with water and brine, dried and concentrated. The compound obtained was used for next step reaction without further purification. Yield 0.816 g, 75percent.
Reference: [1] Patent: WO2008/11478, 2008, A2, . Location in patent: Page/Page column 76
[2] Patent: WO2016/154241, 2016, A1, . Location in patent: Paragraph 578; 579
[3] Patent: US2008/167321, 2008, A1, . Location in patent: Page/Page column 14
[4] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1988, p. 2785 - 2790
[5] Patent: EP1754706, 2007, A1, . Location in patent: Page/Page column 76
[6] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 11, p. 3615 - 3621
  • 17
  • [ 6313-54-8 ]
  • [ 58481-11-1 ]
YieldReaction ConditionsOperation in experiment
73% With thionyl chloride In methanol; toluene Step 1
Preparation of Methyl-2-chloroisonicotinate
To a solution of thionyl chloride (13.85 mL, 190.38 mmol) in toluene (50 mL) was added 2-chloropyridine-4-carboxylic acid (15 g, 95 mmol).
The solution was heated to reflux for 3 hours.
The resulting brown color solution was cooled to room temperature, and methanol (11.56 mL, 285.6 mmol) was added slowly dropwise.
The mixture was brought to reflux for 15 minutes and became clear.
The solution was then cooled to room temperature and poured into water (150 mL), basified with 50 percent sodium hydroxide and extracted with ethyl acetate (2*200 ml).
The organic layer was separated and washed with brine, dried with magnesium sulfate, filtered and concentrated to yield the titled compound (11.93 g, 73percent) as a brown color solid.
This was used in the next step without further purification.
83% With thionyl chloride In methanol; water; toluene Step 2
Preparation of Methyl 2-Chloroisonicotinate:
To a solution of thionyl chloride (15.0 g, 0.127 mol) in 20 mL of toluene was added 2-chloroisonicotinic acid (10.0 g, 0.063 mol) and the reaction was heated at reflux until gas evolution ceased.
Then a solution of methanol (7.7 mL, 0.19 mol) in 10 mL of toluene was added at room temperature over 15 min.
The reaction mixture was then refluxed for 1 h and then cooled to room temperature.
The clear solution was poured into 100 mL of water, basified with 40percent NaOH and extracted with ethyl acetate.
The organic layer was washed with brine, dried over magnesium sulfate filtered.
The filtrate was concentrated in vacuo to give 8.2 g (83percent) of product as a brown oil which solidified upon standing, mp: 36-37 C.
Reference: [1] Patent: US6509361, 2003, B1,
[2] Helvetica Chimica Acta, 1951, vol. 34, p. 496,499
[3] Patent: US6509361, 2003, B1,
[4] Patent: US6316464, 2001, B1,
  • 18
  • [ 6313-54-8 ]
  • [ 34472-65-6 ]
  • [ 58481-11-1 ]
Reference: [1] Patent: WO2009/32667, 2009, A1, . Location in patent: Page/Page column 187
  • 19
  • [ 6313-54-8 ]
  • [ 33972-97-3 ]
Reference: [1] Patent: WO2013/97773, 2013, A1,
  • 20
  • [ 6313-54-8 ]
  • [ 13362-28-2 ]
  • [ 13362-30-6 ]
Reference: [1] Patent: US6096753, 2000, A,
  • 21
  • [ 6313-54-8 ]
  • [ 74-88-4 ]
  • [ 26156-51-4 ]
Reference: [1] Patent: EP2816032, 2014, A1, . Location in patent: Paragraph 0455; 0456
  • 22
  • [ 6313-54-8 ]
  • [ 26156-51-4 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1988, p. 2785 - 2790
  • 23
  • [ 6313-54-8 ]
  • [ 6813-38-3 ]
YieldReaction ConditionsOperation in experiment
85% With hydrogenchloride; sodium hydroxide In methanol; water Example 5
5.00 g of 2-chloroisonicotinic acid and 2.80 g of sodium hydroxide are dissolved in a mixture of 20 ml of water and 16 ml of methanol.
Following the addition of 1.02 g of palladium (10percent by weight on activated carbon) as catalyst, the mixture is stirred for 6 h at 80-85° C. at 0.1 MPa.
The catalyst is then filtered off.
Following acidification to pH 1 using hydrochloric acid, the product, 2,2'-bipyridyl-4,4'-dicarboxylic acid, precipitates out as a white solid.
This gives 3.3 g (85percent yield).
Reference: [1] Patent: US6500956, 2002, B1,
  • 24
  • [ 6313-54-8 ]
  • [ 64-17-5 ]
  • [ 54453-93-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 6, p. 1667 - 1675
[2] Patent: WO2005/70934, 2005, A1, . Location in patent: Page/Page column 39-40; 81-82
[3] Patent: WO2003/99787, 2003, A1, . Location in patent: Page 21
[4] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 8, p. 2286 - 2297
  • 25
  • [ 6313-54-8 ]
  • [ 54453-93-9 ]
Reference: [1] Patent: US6362336, 2002, B1, . Location in patent: Example 58
[2] Patent: US2004/248884, 2004, A1, . Location in patent: Page 120
  • 26
  • [ 6313-54-8 ]
  • [ 79-37-8 ]
  • [ 54453-93-9 ]
Reference: [1] Patent: US5962458, 1999, A,
  • 27
  • [ 6313-54-8 ]
  • [ 66572-56-3 ]
Reference: [1] Journal of Porphyrins and Phthalocyanines, 2015, vol. 19, # 1-3, p. 344 - 351
  • 28
  • [ 6313-54-8 ]
  • [ 89937-77-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2005, vol. 13, # 12, p. 4022 - 4036
  • 29
  • [ 6313-54-8 ]
  • [ 100704-10-7 ]
YieldReaction ConditionsOperation in experiment
99%
Stage #1: With 1,1'-carbonyldiimidazole In tetrahydrofuran at 20℃;
Stage #2: With sodium tetrahydroborate In tetrahydrofuran; water at 0℃; for 0.166667 h;
Stage #3: With hydrogenchloride In tetrahydrofuran; water
Carbonyldiimidazole (CDI, 7.88 g, 46.2 mmol, 1.5 equiv) is added at room temperature to a solution of 2-chloroisonicotinic acid (5.0 g, 30.8 mmol) in THF (70 ml). The reaction mixture is stirred at rt overnight, and then added dropwise to a cold (0 0C) solution of NaBH4 (6.07 g, 154 mmol, 5.0 eq) in water (175 ml). After stirring for 10 minutes at 0 0C, HCI (2 M aqueous solution) is carefully added. Volatiles are removed via rotary evaporation, and the residue is dissolved in an aqueous 10percent solution of NaHCO3. After five extractions with EtOAc, the combined organic layers are dried over Na2SO4, filtered and concentrated in vacuo. 1H-NMR analysis of the residue indicated adequate purity for direct use of the product (4.40 g, 99percent) in the next step. 1H NMR (400 MHz, CDCI3): δ = 8.37 (d, J = 5.1 Hz, 1 H), 7.39 (s, 1 H), 7.23 (d, J = 5.1 Hz, 1H), 4.78 (s, 2H). MS (ES+): 144 (M+H)+.
93%
Stage #1: With dimethylsulfide borane complex In tetrahydrofuran at 0 - 50℃; for 61 h;
Stage #2: With water; ammonium chloride In tetrahydrofuran; ethyl acetate at 20℃;
Borane-dimethyl sulfide complex (14.30 mL, 14.30 mmols) was added to tetrahydrofuran solution of 2-chloroisonicotinic acid (17.56 g, 11.5 mmols) under cooling with ice, and stirred at room temperature for 2.5 days, followed by further an hour's stirring at 50°C. Cooling the reaction liquid to room temperature, ethyl acetate was added, followed by washing with saturated aqueous ammonium chloride solution and saturated brine and drying over anhydrous sodium sulfate. Concentrating the solvent under reduced pressure, the title compound (15.0 g, 93percent) was obtained.
85.8%
Stage #1: With sodium tetrahydroborate; boron trifluoride diethyl etherate In tetrahydrofuran at -10 - 20℃;
Stage #2: With water In tetrahydrofuran
Preparation B-11; A. 2-Chloro-4-(chloromethyl)pyridine; Boron trifluoride diethyl etherate (71 g, 0.5 mol) was added dropwise to a suspension of 2-chloroisonicotinic acid (20 g, 0.125 mol) and sodium borohydride (14.3 g, 0.376 mol) in THF (200 ml.) with stirring at -10-5 0C, then the mixture was stirred at room temperature overnight. The reaction mixture was quenched with water (100 ml_), and extracted with ethyl acetate (3 *200 ml_). The organic layers were combined, washed with brine (200 ml_), dried over anhydrous Na2SO4, filtered and concentrated to dryness. The crude material was further purified by silica gel chromatography (EtOAc/Hexane=1 IA) and afforded 2-chloro-4- (hydroxymethyl)pyridine (15.4 g, 85.8 percent yield) as an oil.
60%
Stage #1: With dimethylsulfide borane complex In tetrahydrofuran at 0 - 20℃; for 49 h;
Stage #2: With hydrogenchloride In tetrahydrofuran; water at 0℃; for 0.5 h;
Stage #3: With sodium hydroxide In tetrahydrofuran; water
(2-Chloro-pyridin-4-yl)-methanol:; To a stirred solution of 2-chloroisonicotinic acid (3.15 g, 20 mmol) in anhydrous THF (40 ml) cooled in an ice bath, was added borane-methyl sulfide complex (6 mL, 60 mmol). After 1 hr, the mixture was stirred for 48 hr at room temperature. The mixture was cooled in an ice bath and conc. HCl (30 ml) was added and stirred for 30 min. The mixture was then basified by addition of 50percent aqueous NaOH (30 ml). The product was extracted with dichloromethane, dried with anhydrous potassium carbonate, filtered, and evaporated in vacuo. The crude product was purified by silica gel column chromatography (eluent, ether:hexane (5:1)) to afford 172 g (60percent) of 2-chloro-4-pyridinemethanol as a white solid. m.p. 77-79° C.; 1H NMR (200 MHz, CDCl3) δ 2.97(1H, br. s), 4.74 (2H, s), 7.20 (1H, d, J=5.7 Hz), 7.36 (1H, s), 8.28 (1H, d, J=5.7 Hz).
60%
Stage #1: With borane-THF In tetrahydrofuran at 50℃;
Stage #2: With methanol In tetrahydrofuran at 20℃;
Example 4: Synthesis of (2-(2-(l H-indazol-4-yl)pyridin-4-yl)-l -fluoroethane-1 ,1 - diyl)diphosphonic acidStep 4a: Synthesis of (2-chloropyridin-4-yl)methanol2-Chl oroi son icot inic acid (2.0 g; 12.7 mmol) is dissolved in 25 mL THF under anhydrous conditions and borane (1.0 M in THF; 25.4 ml; 25.4 mmol) is added drop wise via a syringe. The solution is stirred overnight at 50 °C. The mixture is cooled to R Γ and quenched with 5 mL MeOH, concentrated under reduced pressure and purified by column chromatography on silica gel using a solvent gradient of hexanes to EtOAc. The final product is isolated as a white powder (1.1 g, 60percent yield). NMR (300 MHz, CDC3/4): δ 8.34 (d, J = 5.1 Hz, 1H), 7.36 (dq, J = 1.6, 0.8 Hz, 1H), 7.22 - 7.19 (m, lH). 4.75 (s, 2H).

Reference: [1] Patent: WO2008/74752, 2008, A2, . Location in patent: Page/Page column 11-12
[2] Patent: EP1741703, 2007, A1, . Location in patent: Page/Page column 80
[3] Patent: WO2010/7374, 2010, A1, . Location in patent: Page/Page column 38-39
[4] Patent: US2008/70920, 2008, A1, . Location in patent: Page/Page column 98
[5] Patent: WO2011/147038, 2011, A1, . Location in patent: Page/Page column 43
[6] Patent: US5969140, 1999, A,
[7] Patent: US2009/82379, 2009, A1, . Location in patent: Page/Page column 24
[8] Patent: US2012/225876, 2012, A1, . Location in patent: Page/Page column 39
[9] Patent: WO2016/128529, 2016, A1, . Location in patent: Paragraph 01120; 01121; 01122
[10] Patent: WO2018/15410, 2018, A1, . Location in patent: Paragraph 0428-0431
[11] Patent: WO2008/11478, 2008, A2,
  • 30
  • [ 6313-54-8 ]
  • [ 917-54-4 ]
  • [ 23794-15-2 ]
Reference: [1] Patent: EP1439174, 2004, A1, . Location in patent: Page 88
  • 31
  • [ 6313-54-8 ]
  • [ 23794-15-2 ]
Reference: [1] Patent: US2012/225876, 2012, A1,
[2] Patent: EP2952510, 2015, A1,
[3] Patent: WO2016/97351, 2016, A1,
  • 32
  • [ 6313-54-8 ]
  • [ 83004-15-3 ]
Reference: [1] Patent: WO2011/147038, 2011, A1,
  • 33
  • [ 6313-54-8 ]
  • [ 80194-83-8 ]
Reference: [1] Patent: WO2012/142513, 2012, A1,
  • 34
  • [ 6313-54-8 ]
  • [ 72716-87-1 ]
Reference: [1] Patent: EP2816032, 2014, A1,
  • 35
  • [ 6313-54-8 ]
  • [ 123148-66-3 ]
Reference: [1] Patent: EP2816032, 2014, A1,
  • 36
  • [ 6313-54-8 ]
  • [ 104-94-9 ]
  • [ 85726-29-0 ]
Reference: [1] Polish Journal of Chemistry, 1981, vol. 55, # 7/8, p. 1667 - 1672
  • 37
  • [ 6313-54-8 ]
  • [ 101066-61-9 ]
Reference: [1] Patent: WO2008/11478, 2008, A2,
  • 38
  • [ 6313-54-8 ]
  • [ 639091-78-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2005, vol. 13, # 12, p. 4022 - 4036
  • 39
  • [ 6313-54-8 ]
  • [ 36805-97-7 ]
  • [ 295349-62-1 ]
YieldReaction ConditionsOperation in experiment
56% for 2 h; Heating / reflux A solution of 10.0 g (63.4 mmol) 2-chloro-isonicotinic acid in 100 ml chloroform is heated to reflux temperature. In total 91.2 ml (380 mmol, 6 eq) N,N-dimethylformamide di-tert-butylacetal is added in 3 portions of each 30.4 ml at the start, after 1 h and after 2 h. After cooling to rt the mixture is diluted with EtOAc, washed with aq. bicarbonate and brine, and dried over sodium sulfate. The residue is purified by chromatography on silica (flashmaster, hexane to hexane/EtOAc 95/5) to give 7.6 g (35.6 mmol, 56percent) of the product as white solid.MS (LC/MS): 158=[M+H-tBu]+ 1H-NMR (300 MHz, CDCl3): 8.55 (d, 1H), 7.85 (s, 1H), 7.76 (d, 1H), 1.64 (s, 9H).
33% at 90℃; for 20 h; a) To a solution of 2-chloroisonicotinic acid (5.00 g, 31.7 mmol) in toluene is added N,Ndimethylformamide di-tert. butylacetal (17.9 g, 79.3 mmol). The mixture is stirred at 90°C for 20 h. The mixture is concentrated, filtered and the filtrate is diluted with EA and washed with water, dried over MgSO4, filtered and concentrated. The crude product is purified by CC on silica gel eluting heptane:EA 5:1 to give tert. butyl 2-chloroisonicotinate (2.23 g, 33percent) as a colourless oil; LC-MS: tR = 0.98 mm, [M+1+CH3CN] = 255.31.
Reference: [1] Patent: US2008/132477, 2008, A1, . Location in patent: Page/Page column 28
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 1, p. 110 - 130
[3] Patent: WO2014/141171, 2014, A1, . Location in patent: Page/Page column 17; 18
  • 40
  • [ 6313-54-8 ]
  • [ 24424-99-5 ]
  • [ 295349-62-1 ]
Reference: [1] Patent: WO2008/11499, 2008, A1, . Location in patent: Page/Page column 37
[2] Organic Process Research and Development, 2009, vol. 13, # 6, p. 1145 - 1155
  • 41
  • [ 6313-54-8 ]
  • [ 67098-46-8 ]
  • [ 295349-62-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 14, p. 4233 - 4249
  • 42
  • [ 6313-54-8 ]
  • [ 474327-26-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 19, p. 6218 - 6223
[2] Patent: WO2010/93849, 2010, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 6313-54-8 ]

Chlorides

Chemical Structure| 215306-02-8

[ 215306-02-8 ]

2-Chloropyridine-3,4-dicarboxylic acid

Similarity: 0.86

Chemical Structure| 58483-94-6

[ 58483-94-6 ]

3-Amino-2-chloroisonicotinic acid

Similarity: 0.85

Chemical Structure| 295349-62-1

[ 295349-62-1 ]

tert-Butyl 2-chloroisonicotinate

Similarity: 0.85

Chemical Structure| 5398-44-7

[ 5398-44-7 ]

2,6-Dichloroisonicotinic acid

Similarity: 0.83

Chemical Structure| 73781-91-6

[ 73781-91-6 ]

Methyl 6-chloronicotinate

Similarity: 0.83

Carboxylic Acids

Chemical Structure| 215306-02-8

[ 215306-02-8 ]

2-Chloropyridine-3,4-dicarboxylic acid

Similarity: 0.86

Chemical Structure| 58483-94-6

[ 58483-94-6 ]

3-Amino-2-chloroisonicotinic acid

Similarity: 0.85

Chemical Structure| 55-22-1

[ 55-22-1 ]

4-Pyridinecarboxylic acid

Similarity: 0.84

Chemical Structure| 5398-44-7

[ 5398-44-7 ]

2,6-Dichloroisonicotinic acid

Similarity: 0.83

Chemical Structure| 58483-95-7

[ 58483-95-7 ]

5-Amino-2-chloropyridine-4-carboxylic acid

Similarity: 0.82

Related Parent Nucleus of
[ 6313-54-8 ]

Pyridines

Chemical Structure| 215306-02-8

[ 215306-02-8 ]

2-Chloropyridine-3,4-dicarboxylic acid

Similarity: 0.86

Chemical Structure| 58483-94-6

[ 58483-94-6 ]

3-Amino-2-chloroisonicotinic acid

Similarity: 0.85

Chemical Structure| 295349-62-1

[ 295349-62-1 ]

tert-Butyl 2-chloroisonicotinate

Similarity: 0.85

Chemical Structure| 55-22-1

[ 55-22-1 ]

4-Pyridinecarboxylic acid

Similarity: 0.84

Chemical Structure| 5398-44-7

[ 5398-44-7 ]

2,6-Dichloroisonicotinic acid

Similarity: 0.83